BioArctic AB (publ) reported earnings results for the third quarter and nine months ended September 30, 2023. For the third quarter, the company reported sales was SEK 208.84 million compared to SEK 218.23 million a year ago. Revenue was SEK 209.14 million compared to SEK 218.89 million a year ago. Net income was SEK 124.95 million compared to SEK 136.79 million a year ago. Basic earnings per share from continuing operations was SEK 1.42 compared to SEK 1.55 a year ago. Diluted earnings per share from continuing operations was SEK 1.41 compared to SEK 1.54 a year ago.
For the nine months, sales was SEK 604.97 million compared to SEK 226.2 million a year ago. Revenue was SEK 608.61 million compared to SEK 227.52 million a year ago. Net income was SEK 316.49 million compared to SEK 46.7 million a year ago. Basic earnings per share from continuing operations was SEK 3.59 compared to SEK 0.53 a year ago. Diluted earnings per share from continuing operations was SEK 3.58 compared to SEK 0.53 a year ago.